Tag: breast cancer
The concept of neoadjuvant therapy in breast cancer
Find out about therapy before surgery (neoadjuvant) in breast cancer. In this blog, we cover
the main aspects, its impact on surgery and long-term outcomes.
Hormone therapy resistance: What you should know
Find out what hormone therapy resistance means, how it happens, and how it may affect you and your treatment plan.
Untangling monoclonal antibodies – Trastuzumab, Pertuzumab, Atezolizumab
We know that drug names can be confusing. That’s why we’re untangling drug terminology. Starting with the monoclonal antibodies (AKA the mabs).
Demystifying fear of cancer recurrence
Fear of cancer recurrence is one of the most common psychosocial effects of cancer. Find out what it is and how to manage it.
Hot flushes: What causes them and how to manage them
Are you experiencing hot flushes? This blog explores what causes them and tips to help you manage them.
Your Pathology Results Explained
In the first of our series ‘Breast cancer under the microscope’, better understand your pathology report.
Tamoxifen vs. Aromatase Inhibitors – How do they work?
Both tamoxifen and aromatase inhibitors are hormonal therapies used in the treatment of oestrogen positive breast cancers to stop tumour growth and recurrence.
5 Facts You May Not Know About Breast Cancer
From its first record to the discovery of its common treatments, uncover more about breast cancer.
BRCA: the inherited risk of breast cancer
BRCA genes are the most well-known genetic factors influencing the risk of cancer. Explore exactly what they are, their associated risk of breast cancer, and treatments in development to target these genes.
HER2 and Herceptin®: A Look at the History
The discovery of the HER2 gene led to the development of Herceptin®: a targeted therapy that is widely used today for HER2+ breast cancer patients.
Chemobrain without having chemotherapy?
Cognitive decline (chemobrain) is usually only spoken about as being a side effect of chemotherapy, yet studies have shown that other treatments can cause chemobrain.
Evaluating mobile applications for Breast Cancer in Germany: A systematic review
A systematic review that evaluated if breast cancer apps can support patients, whereby the OWise app received the highest score.